Diet, the Gut Microbiome, and Estrogen Physiology: A Review in Menopausal Health and Interventions
Top Cited Papers
Open Access
Abstract
Menopause represents a key transitional phase in women’s health, characterized by declining estrogen levels and increased risk for cardiometabolic, musculoskeletal, and urogenital disorders. Beyond its endocrine roots, emerging evidence highlights the gut microbiome as a critical modulator of systemic hormonal balance. This review synthesizes current understanding of the bidirectional relationship between estrogen and the gut microbiome and its implications for women’s health during menopause. Evidence from current studies reveals distinct findings across populations, reflecting the complexity of estrogen regulation in part by the gut microbiome (i.e., estrobolome). While no ideal gut microbial composition has been identified for women across stages of perimenopause, likely due to geographically unique gut microbiome profiles among healthy women, greater microbial diversity has been positively associated with improved estrogen regulation. Conversely, reduced diversity and altered Firmicutes/Bacteroidetes ratios have been linked to biomarkers of inflammation during perimenopause, which is a key driver across many perimenopausal symptoms. Although hormone replacement therapy remains the primary clinical intervention during perimenopause, we highlight emerging evidence on the adjuvant potential of diet, synbiotics, phytoestrogens, and strain-specific probiotics in modulating the estrogen–gut microbiome axis for improved health span trajectories and better symptom management. Future longitudinal studies integrating diet, gut microbiome profiles and symptom trajectories are essential to clarify these mechanisms across ethnicity and geography. Ultimately, understanding localized diet–microbiome interactions will enable the development of accessible, personalized, and non-hormonal strategies to complement and increase agency in proactive management during the perimenopausal transition.Keywords
Funding Information
- Agency for Science, Technology and Research (C240314055)
This publication has 220 references indexed in Scilit:
- A randomized, double-blind, placebo-controlled clinical study to evaluate the efficacy of the synbiotic medical food, SBD111, for the clinical dietary management of bone loss in menopausal womenOsteoporosis International, 2025
- The estrobolome: Estrogen‐metabolizing pathways of the gut microbiome and their relation to breast cancerInternational Journal of Cancer, 2025
- From Gut to Hormones: Unraveling the Role of Gut Microbiota in (Phyto)Estrogen Modulation in Health and DiseaseMolecular Nutrition & Food Research, 2024
- Alleviative mechanism and effect of Bifidobacterium animalisA6 on dextran sodium sulfate‐induced ulcerative colitis in miceFood Science & Nutrition, 2022
- Perturbations in Gut Microbiota Composition in Psychiatric DisordersJAMA Psychiatry, 2021
- The Menopause Transition and CognitionJAMA, 2020
- Compositional and functional features of the female premenopausal and postmenopausal gut microbiotaFEBS Letters, 2019
- Duration of Menopausal Vasomotor Symptoms Over the Menopause TransitionJAMA Internal Medicine, 2015
- Effect of a combination GOS/FOS® prebiotic mixture and interaction with calcium intake on mineral absorption and bone parameters in growing ratsEuropean Journal of Nutrition, 2014
- Intestinal bacterial β-glucuronidase activity of patients with colon cancerArchives of Pharmacal Research, 2001